قالب وردپرس درنا توس
Home / Entertainment / Colorado, to limit insulin, pays $ 100 a month

Colorado, to limit insulin, pays $ 100 a month



Colorado Governor Jared Polis reportedly signed a bill last week limiting insulin to $ 100 a month. Legislation is a benefit for diabetics, as the price of insulin continues to rise. According to NPR, the price tripled between 2002 and 2013 and has continued to increase since then.

"Today we will finally declare that the days of insulin price estimation in Colorado are over," Polis said at a press conference. 19659003] COLORADO SIGNS A DOCUMENT REQUIRES THAT DOCTORS RECOMMEND MEDICAL MARIJUANA TO SUPPORT OPIOIDES For coloradans with type 1 diabetes, insulin is vital. It's the same as oxygen, "said Democratic MP Dylan Roberts, whose brother died of diabetes, to Denver's FOX 31

." The skyrocketing cost of insulin is outrageous and literally jeopardizes people's lives. With this new law, Coloradans will no longer be forced to choose between this life-saving and life-sustaining drug and its other issues. "

" This bill saves me $ 35 a month on my private insurance. For other people, this could mean a monthly savings of up to $ 2,000 or more, "said Betsy Ray, an insulin user, about FOX 31 after Polis signed the bill.

" This bill saves me personally 35 US dollars a month because of my private insurance. For others, this could mean a monthly savings of up to $ 2,000 or more.

– Betsy Ray, insulin consumer

Under the new law, which will come into effect in January, Colorado's attorney general will also investigate how insulin prices are fixed in the state: due to increased prices, some patients have had to ration between their existing and non-refill recipe.

<img src = "https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2019/04/640/320/ insulin-injection-wellcome-1024×576.jpg? ve = 1 & tl = 1 "alt =" The price of insulin tripled between 2002 and 2013 The price of insulin tripled between 2002 and 2013, according to NPR, and has continued to increase since then.

A professor from the Pittsburgh School of Pharmacy told NPR that the real problem is that there is not enough competition in the pharmaceutical industry.

This year, insulin manufacturer Eli Lilly plans to launch a generic version of its product. On the market, which would cost half the price, NPR announced last month that one of the largest pharmacy benefit managers capped at 25 USD for insulin co-pays.

CLICK HERE TO OBTAIN THE FOX NEWS APP [19659004] The additional costs should be covered by the insurers.


Source link